Double heterozygosity for hemoglobin G (alpha-2 68Lys beta-A2) and hemoglobin D (alpha A2-beta-121Gln).
D000362:Agar; D000595:Amino Acid Sequence; D000740:Anemia / Q000188:drug therapy; D044383:Black People; D001797:Blood Protein Electrophoresis; D002848:Chromatography, DEAE-Cellulose; D004586:Electrophoresis; D005782:Gels; D005973:Glutamine / Q000032:analysis; D006453:Hemoglobinopathies / Q000235:genetics*; D006455:Hemoglobins, Abnormal / Q000032:analysis / Q000302:isolation & purification*; D006579:Heterozygote; D006801:Humans; D007223:Infant; D007501:Iron / Q000627:therapeutic use; D008239:Lysine / Q000032:analysis; D008297:Male; D008967:Molecular Biology; D010375:Pedigree; D010455:Peptides / Q000032:analysis; D013213:Starch; D014357:Trypsin / Q000494:pharmacology
D005782:Gels; D006455:Hemoglobins, Abnormal; D010455:Peptides; D005973:Glutamine; D000362:Agar; D013213:Starch; D007501:Iron; D014357:Trypsin; D008239:Lysine